Company / Revenue per Share
Decoy Therapeutics Inc. Revenue per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.02
FY2022
5-year range
$0.06 / $1.02
FY2018-FY2022
Trend
+362.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +363% YoY in FY2022, a notable deviation from the 4-year average annual change of +465%.
Based on SEC 10-K filings.
1.02 in FY2022 with a 3-year CAGR of +1.9%.
Improved from $0.77 to $1.02 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +1.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, revenue per share increased 362.6% year-over-year.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $1.02 | +362.6% |
| FY2021 | $0.22 | -71.4% |
| FY2020 | $0.77 | -20.0% |
| FY2019 | $0.96 | +1590.4% |
| FY2018 | $0.06 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026